pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-103b-1 |
Genomic Coordinates | chr5: 168560904 - 168560965 |
Description | Homo sapiens miR-103b-1 stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases | |
pre-miRNA | hsa-mir-103b-2 |
Genomic Coordinates | chr20: 3917502 - 3917563 |
Description | Homo sapiens miR-103b-2 stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-103b | |||||||||||||||||||||
Sequence | 1| UCAUAGCCCUGUACAAUGCUGCU |23 | |||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||
Experiments | ChIP-seq | DRVs in miRNA |
|
|||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | DMTF1 | ||||||||||||||||||||
Synonyms | DMP1, DMTF, MRUL, hDMP1 | ||||||||||||||||||||
Description | cyclin D binding myb like transcription factor 1 | ||||||||||||||||||||
Transcript | NM_021145 | ||||||||||||||||||||
Other Transcripts | NM_001142327 , NM_001142326 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on DMTF1 | |||||||||||||||||||||
3'UTR of DMTF1 (miRNA target sites are highlighted) |
>DMTF1|NM_021145|3'UTR 1 AATAATTCTTAGAAATAGGCAGTTCAAGCAAAGAAGGCACACTGTTAATTACAACCTCTTCAAAGAAATAGGAGCAACCC 81 CCAAGAGGCTTAATTTACCAATTTAAATAGCCACAGTCCTTAAGCCACACACATTGTTGCTGCTATGACTTTTTACCTCC 161 TTTAAACACATCATCTGAGGTTGAGTTTTATGACAGTATGTAGTTGAGTGGAGGCTGGGAGTTTTAAGCATAAATCCCTG 241 TTTAGTGTTACATGGGAATAAGGAATTTCATTCACTTCAGCCACTAAGAAAAGTTTAGAATCACGAAAGCTTAACTGCTG 321 TGGTTTAAAGTACAGTTTCTCTAAAGATCAGACATGGCACTGTCTCCTCTCAAGCCTGGTTGTAGTTCAGATGAGTCTTT 401 TCAACATGGTCTTCAACATGGTCTAGAGCTTACCAGTGATCTTCTGATCTTCAAGAAGACTAAGTTTGAGACTTGACCAG 481 CATACAAGTATAGAGACCTAGGAGGTGGTCTTGTGGTGGTACATTTGGTTAACCCATTGCTGGCAGTGGGAGCTGATTTA 561 GGCAGGGTAAACAGGAAAGCATTAAAAGTTAAAATTCACTACAGGTTTTTTGTTACTTTTAAAGGGAATATGGATAAGCA 641 TAGTAACAAAACCCACCAGAATCTAAGCAGTTTTCACCCCCTCAGAAACCACTGTCATTAGTTTACAAAGTTAGCACTTT 721 GAAGTAAAACTAAATGAGGAAGGAAGTAATGTTACCTATCCTTGATACCATGACCATTTATTAGATGTTTTGCTATATAA 801 ATTACCGAGAGAATAGTTTGTCATCCACTTAGTGTGTTAGCTGGTGGGGTACAATATAACCTCTCATCTCAGGCTATTTT 881 AAAAAAACAATATTTGCTTCTATAACAAAAGGAAACAAATCTAAGAATCATTCCTGTACTACAGAAGGGTTAAGGCAAAG 961 GTAGCCTTTTGGGCTTTTTAATGAATATGACCCCTATAGAAAAGTCAAGAAAAAAAAACCCTTGTATAAATTATTTTATT 1041 TATTATTGTAATTAGATCTTCACAAAGTTGTCTTTTCACTGTGTTTTGTCAACGTGAAATTAAATTGTAGTTATAAGCAA 1121 AAGTTGGTTGCCTAGGGAACAATTGTATATTCAGTTTAACAGAAATAAAAGAATATTTGTCTTAAGATGCAAAAAAAAAA 1201 AAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 9988.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714644. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
CLIP-seq Support 1 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_001142327 | 3UTR | AAAGAAAUAGGAGCAACCCCCAAGAGGCUUAAUUUACCAAUUUAAAUAGCCACAGUCCUUAAGCCACACACAUUGUUGCUGCUAUGACUUUUUACCUCCUUUAAACACAUCAUCUGAGGUUGAGUUUUAUGACAGUAUGUAGUUGAGUGGAGGCUGGGAGUUUUAAGCAUAAAUCCCUGUUUAGUGUUACAUGGGAAUAAGGA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903834 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_b |
Location of target site | NM_001142327 | 3UTR | UAGGAGCAACCCCCAAGAGGCUUAAUUUACCAAUUUAAAUAGCCACAGUCCUUAAGCCACACACAUUGUUGCUGCUAUGACUUUUUACCUCCUUUAAACACAUCAUCUGAGGUUGAGUUUUAUGACAGUAUGUAGUUGAGUGGAGGCUGGGAGUUUUAAGCAUAAAUCCCUGUUUAGUGUUACAUGGGAAUAAGGA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM4903835 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_c |
Location of target site | NM_001142327 | 3UTR | UUCAAAGAAAUAGGAGCAACCCCCAAGAGGCUUAAUUUACCAAUUUAAAUAGCCACAGUCCUUAAGCCACACACAUUGUUGCUGCUAUGACUUUUUACCUCCUUUAAACACAUCAUCUGAGGUUGAGUUUUAUGACAGUAUGUAGUUGAGUGGAGGCUGGGAGUUUUAAGCAUAAAUCCCUGUUUAGUGUUACAUGGGAAUAAGGA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM4903836 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_a |
Location of target site | NM_001142327 | 3UTR | GAGCAACCCCCAAGAGGCUUAAUUUACCAAUUUAAAUAGCCACAGUCCUUAAGCCACACACAUUGUUGCUGCUAUGACUUUUUACCUCCUUUAAACACAUCAUCUGAGGUUGAGUUUUAUGACAGUAUGUAGUUGAGUGGAGGCUGGGAGUUUUAAGCAUAAAUCCCUGUUUAGUGUUACAUGGGAAUAAGGA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM4903837 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_b |
Location of target site | NM_001142327 | 3UTR | CCAAGAGGCUUAAUUUACCAAUUUAAAUAGCCACAGUCCUUAAGCCACACACAUUGUUGCUGCUAUGACUUUUUACCUCCUUUAAACACAUCAUCUGAGGUUGAGUUUUAUGACAGUAUGUAGUUGAGUGGAGGCUGGGAGUUUUAAGCAUAAAUCCCUGUUUAGUGUUACAUGGGAAUAAGGA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM4903838 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_c |
Location of target site | NM_001142327 | 3UTR | AACCCCCAAGAGGCUUAAUUUACCAAUUUAAAUAGCCACAGUCCUUAAGCCACACACAUUGUUGCUGCUAUGACUUUUUACCUCCUUUAAACACAUCAUCUGAGGUUGAGUUUUAUGACAGUAUGUAGUUGAGUGGAGGCUGGGAGUUUUAAGCAUAAAUCCCUGUUUAGUGUUACAUGGGAAUAAGGA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset GSM714644 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repA |
Location of target site | ENST00000413276.2 | 3UTR | CCACACACAUUGUUGCUGCUAUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
53 hsa-miR-103b Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT218386 | E2F3 | E2F transcription factor 3 | 2 | 2 | ||||||||
MIRT404221 | RPL7L1 | ribosomal protein L7 like 1 | 2 | 2 | ||||||||
MIRT441502 | SPG20 | spartin | 2 | 6 | ||||||||
MIRT444124 | ZNRF3 | zinc and ring finger 3 | 2 | 2 | ||||||||
MIRT454236 | OSBPL10 | oxysterol binding protein like 10 | 2 | 4 | ||||||||
MIRT457919 | ZNF212 | zinc finger protein 212 | 2 | 2 | ||||||||
MIRT462254 | LAMA4 | laminin subunit alpha 4 | 2 | 2 | ||||||||
MIRT463176 | ZNF281 | zinc finger protein 281 | 2 | 2 | ||||||||
MIRT472355 | TSPAN1 | tetraspanin 1 | 2 | 2 | ||||||||
MIRT474133 | LIN54 | lin-54 DREAM MuvB core complex component | 2 | 4 | ||||||||
MIRT494946 | IFFO2 | intermediate filament family orphan 2 | 2 | 2 | ||||||||
MIRT497403 | NPY4R | neuropeptide Y receptor Y4 | 2 | 2 | ||||||||
MIRT497641 | GLDN | gliomedin | 2 | 2 | ||||||||
MIRT505340 | TMEM245 | transmembrane protein 245 | 2 | 6 | ||||||||
MIRT505680 | SESTD1 | SEC14 and spectrin domain containing 1 | 2 | 6 | ||||||||
MIRT510706 | SREK1IP1 | SREK1 interacting protein 1 | 2 | 6 | ||||||||
MIRT512198 | C1orf43 | chromosome 1 open reading frame 43 | 2 | 2 | ||||||||
MIRT522089 | NUFIP2 | NUFIP2, FMR1 interacting protein 2 | 2 | 4 | ||||||||
MIRT525074 | FRK | fyn related Src family tyrosine kinase | 2 | 2 | ||||||||
MIRT531276 | PPIL3 | peptidylprolyl isomerase like 3 | 2 | 2 | ||||||||
MIRT535119 | PLXNA2 | plexin A2 | 2 | 2 | ||||||||
MIRT540836 | GNAT1 | G protein subunit alpha transducin 1 | 2 | 4 | ||||||||
MIRT541018 | WIPI2 | WD repeat domain, phosphoinositide interacting 2 | 2 | 2 | ||||||||
MIRT545752 | CA12 | carbonic anhydrase 12 | 2 | 4 | ||||||||
MIRT546404 | SRP9 | signal recognition particle 9 | 2 | 2 | ||||||||
MIRT547991 | HCFC2 | host cell factor C2 | 2 | 4 | ||||||||
MIRT554502 | SAE1 | SUMO1 activating enzyme subunit 1 | 2 | 2 | ||||||||
MIRT558360 | DMTF1 | cyclin D binding myb like transcription factor 1 | 2 | 2 | ||||||||
MIRT558863 | CD2AP | CD2 associated protein | 2 | 2 | ||||||||
MIRT559939 | ZNF567 | zinc finger protein 567 | 2 | 2 | ||||||||
MIRT566300 | PPM1A | protein phosphatase, Mg2+/Mn2+ dependent 1A | 2 | 2 | ||||||||
MIRT567490 | FOXK1 | forkhead box K1 | 2 | 2 | ||||||||
MIRT617139 | ZNF556 | zinc finger protein 556 | 2 | 2 | ||||||||
MIRT625400 | AKR7L | aldo-keto reductase family 7 like (gene/pseudogene) | 2 | 2 | ||||||||
MIRT626491 | CEP89 | centrosomal protein 89 | 2 | 2 | ||||||||
MIRT629487 | GSN | gelsolin | 2 | 4 | ||||||||
MIRT638456 | PLXDC2 | plexin domain containing 2 | 2 | 2 | ||||||||
MIRT648498 | CMBL | carboxymethylenebutenolidase homolog | 2 | 2 | ||||||||
MIRT654845 | PPM1L | protein phosphatase, Mg2+/Mn2+ dependent 1L | 2 | 2 | ||||||||
MIRT664587 | HSD17B12 | hydroxysteroid 17-beta dehydrogenase 12 | 2 | 2 | ||||||||
MIRT664977 | TDRD1 | tudor domain containing 1 | 2 | 2 | ||||||||
MIRT665028 | ELK1 | ELK1, ETS transcription factor | 2 | 2 | ||||||||
MIRT666043 | STON2 | stonin 2 | 2 | 2 | ||||||||
MIRT668863 | CRY2 | cryptochrome circadian clock 2 | 2 | 2 | ||||||||
MIRT669297 | C17orf85 | nuclear cap binding subunit 3 | 2 | 2 | ||||||||
MIRT680975 | DCAF17 | DDB1 and CUL4 associated factor 17 | 2 | 2 | ||||||||
MIRT682267 | RS1 | retinoschisin 1 | 2 | 2 | ||||||||
MIRT685283 | KIAA1143 | KIAA1143 | 2 | 2 | ||||||||
MIRT693375 | PIGP | phosphatidylinositol glycan anchor biosynthesis class P | 2 | 2 | ||||||||
MIRT701785 | MSL1 | male specific lethal 1 homolog | 2 | 2 | ||||||||
MIRT709373 | SPECC1 | sperm antigen with calponin homology and coiled-coil domains 1 | 2 | 2 | ||||||||
MIRT715154 | IL12B | interleukin 12B | 2 | 2 | ||||||||
MIRT734499 | ADAMTS5 | ADAM metallopeptidase with thrombospondin type 1 motif 5 | 3 | 0 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|